Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 30, 2023

BUY
$1.07 - $1.34 $73,751 - $92,362
68,927 New
68,927 $83,000
Q2 2022

Aug 04, 2022

BUY
$1.13 - $3.69 $253,733 - $828,563
224,543 New
224,543 $335,000
Q2 2020

Aug 07, 2020

SELL
$4.78 - $8.26 $1.24 Million - $2.14 Million
-258,628 Closed
0 $0
Q1 2020

May 06, 2020

SELL
$4.0 - $21.53 $77,864 - $419,102
-19,466 Reduced 7.0%
258,628 $1.04 Million
Q4 2019

Feb 05, 2020

BUY
$13.94 - $24.12 $339,271 - $587,032
24,338 Added 9.59%
278,094 $5.96 Million
Q3 2019

Nov 07, 2019

BUY
$13.89 - $23.16 $3.25 Million - $5.43 Million
234,252 Added 1201.05%
253,756 $3.85 Million
Q2 2019

Aug 09, 2019

BUY
$16.27 - $20.51 $114,134 - $143,877
7,015 Added 56.17%
19,504 $378,000
Q4 2018

Feb 08, 2019

BUY
$12.41 - $22.98 $154,988 - $286,997
12,489 New
12,489 $170,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.